The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don’t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections. Zika virus testing is recommended only for certain people. People live in or traveled to an area with risk of Zika; People had sex without a condom with a partner who lives in or traveled to an area with risk of Zika; Pregnant women who don’t have Zika symptoms lives in or traveled to an area with risk of Zika.
The global Zika Virus market was valued at US$ 116 million in 2023 and is anticipated to reach US$ 144 million by 2030, witnessing a CAGR of 3.1% during the forecast period 2024-2030.
Global Zika Virus key players include Chembio, Quest Diagnostics, ARUP Laboratories, Luminex Corporation, Simens, etc. Global top five manufacturers hold a share about 55%. North Amercia is the largest market, with a share about 45%, followed by Europe, with a share about 30 percent. In terms of product, Molecular Test is the largest segment, with a share about 90%. And in terms of application, the largest application is Diagnostic Centers, followed by Hospitals, Pathology Labs.
This report aims to provide a comprehensive presentation of the global market for Zika Virus, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Zika Virus.
Report Scope
The Zika Virus market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Zika Virus market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Zika Virus manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bharat Biotech
Inovio Pharmaceuticals and GeneOne Life Sciences
Intrexon
Cerus
Sanofi
NewLink Genetics
Immunovaccine
GlaxoSmithKline
Segment by Type
Molecular Test
Serologic Test
Segment by Application
Diagnostic Centers
Hospitals
Pathology Labs
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Zika Virus manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Zika Virus in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don’t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections. Zika virus testing is recommended only for certain people. People live in or traveled to an area with risk of Zika; People had sex without a condom with a partner who lives in or traveled to an area with risk of Zika; Pregnant women who don’t have Zika symptoms lives in or traveled to an area with risk of Zika.
The global Zika Virus market was valued at US$ 116 million in 2023 and is anticipated to reach US$ 144 million by 2030, witnessing a CAGR of 3.1% during the forecast period 2024-2030.
Global Zika Virus key players include Chembio, Quest Diagnostics, ARUP Laboratories, Luminex Corporation, Simens, etc. Global top five manufacturers hold a share about 55%. North Amercia is the largest market, with a share about 45%, followed by Europe, with a share about 30 percent. In terms of product, Molecular Test is the largest segment, with a share about 90%. And in terms of application, the largest application is Diagnostic Centers, followed by Hospitals, Pathology Labs.
This report aims to provide a comprehensive presentation of the global market for Zika Virus, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Zika Virus.
Report Scope
The Zika Virus market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Zika Virus market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Zika Virus manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bharat Biotech
Inovio Pharmaceuticals and GeneOne Life Sciences
Intrexon
Cerus
Sanofi
NewLink Genetics
Immunovaccine
GlaxoSmithKline
Segment by Type
Molecular Test
Serologic Test
Segment by Application
Diagnostic Centers
Hospitals
Pathology Labs
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Zika Virus manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Zika Virus in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Zika Virus Market Overview
1.1 Product Overview and Scope of Zika Virus
1.2 Zika Virus Segment by Type
1.2.1 Global Zika Virus Market Value Comparison by Type (2024-2030)
1.2.2 Molecular Test
1.2.3 Serologic Test
1.3 Zika Virus Segment by Application
1.3.1 Global Zika Virus Market Value by Application: (2024-2030)
1.3.2 Diagnostic Centers
1.3.3 Hospitals
1.3.4 Pathology Labs
1.4 Global Zika Virus Market Size Estimates and Forecasts
1.4.1 Global Zika Virus Revenue 2019-2030
1.4.2 Global Zika Virus Sales 2019-2030
1.4.3 Global Zika Virus Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Zika Virus Market Competition by Manufacturers
2.1 Global Zika Virus Sales Market Share by Manufacturers (2019-2024)
2.2 Global Zika Virus Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Zika Virus Average Price by Manufacturers (2019-2024)
2.4 Global Zika Virus Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Zika Virus, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Zika Virus, Product Type & Application
2.7 Zika Virus Market Competitive Situation and Trends
2.7.1 Zika Virus Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Zika Virus Players Market Share by Revenue
2.7.3 Global Zika Virus Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Zika Virus Retrospective Market Scenario by Region
3.1 Global Zika Virus Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Zika Virus Global Zika Virus Sales by Region: 2019-2030
3.2.1 Global Zika Virus Sales by Region: 2019-2024
3.2.2 Global Zika Virus Sales by Region: 2025-2030
3.3 Global Zika Virus Global Zika Virus Revenue by Region: 2019-2030
3.3.1 Global Zika Virus Revenue by Region: 2019-2024
3.3.2 Global Zika Virus Revenue by Region: 2025-2030
3.4 North America Zika Virus Market Facts & Figures by Country
3.4.1 North America Zika Virus Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Zika Virus Sales by Country (2019-2030)
3.4.3 North America Zika Virus Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Zika Virus Market Facts & Figures by Country
3.5.1 Europe Zika Virus Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Zika Virus Sales by Country (2019-2030)
3.5.3 Europe Zika Virus Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Zika Virus Market Facts & Figures by Country
3.6.1 Asia Pacific Zika Virus Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Zika Virus Sales by Country (2019-2030)
3.6.3 Asia Pacific Zika Virus Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Zika Virus Market Facts & Figures by Country
3.7.1 Latin America Zika Virus Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Zika Virus Sales by Country (2019-2030)
3.7.3 Latin America Zika Virus Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Zika Virus Market Facts & Figures by Country
3.8.1 Middle East and Africa Zika Virus Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Zika Virus Sales by Country (2019-2030)
3.8.3 Middle East and Africa Zika Virus Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Zika Virus Sales by Type (2019-2030)
4.1.1 Global Zika Virus Sales by Type (2019-2024)
4.1.2 Global Zika Virus Sales by Type (2025-2030)
4.1.3 Global Zika Virus Sales Market Share by Type (2019-2030)
4.2 Global Zika Virus Revenue by Type (2019-2030)
4.2.1 Global Zika Virus Revenue by Type (2019-2024)
4.2.2 Global Zika Virus Revenue by Type (2025-2030)
4.2.3 Global Zika Virus Revenue Market Share by Type (2019-2030)
4.3 Global Zika Virus Price by Type (2019-2030)
5 Segment by Application
5.1 Global Zika Virus Sales by Application (2019-2030)
5.1.1 Global Zika Virus Sales by Application (2019-2024)
5.1.2 Global Zika Virus Sales by Application (2025-2030)
5.1.3 Global Zika Virus Sales Market Share by Application (2019-2030)
5.2 Global Zika Virus Revenue by Application (2019-2030)
5.2.1 Global Zika Virus Revenue by Application (2019-2024)
5.2.2 Global Zika Virus Revenue by Application (2025-2030)
5.2.3 Global Zika Virus Revenue Market Share by Application (2019-2030)
5.3 Global Zika Virus Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bharat Biotech
6.1.1 Bharat Biotech Corporation Information
6.1.2 Bharat Biotech Description and Business Overview
6.1.3 Bharat Biotech Zika Virus Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bharat Biotech Zika Virus Product Portfolio
6.1.5 Bharat Biotech Recent Developments/Updates
6.2 Inovio Pharmaceuticals and GeneOne Life Sciences
6.2.1 Inovio Pharmaceuticals and GeneOne Life Sciences Corporation Information
6.2.2 Inovio Pharmaceuticals and GeneOne Life Sciences Description and Business Overview
6.2.3 Inovio Pharmaceuticals and GeneOne Life Sciences Zika Virus Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Inovio Pharmaceuticals and GeneOne Life Sciences Zika Virus Product Portfolio
6.2.5 Inovio Pharmaceuticals and GeneOne Life Sciences Recent Developments/Updates
6.3 Intrexon
6.3.1 Intrexon Corporation Information
6.3.2 Intrexon Description and Business Overview
6.3.3 Intrexon Zika Virus Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Intrexon Zika Virus Product Portfolio
6.3.5 Intrexon Recent Developments/Updates
6.4 Cerus
6.4.1 Cerus Corporation Information
6.4.2 Cerus Description and Business Overview
6.4.3 Cerus Zika Virus Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cerus Zika Virus Product Portfolio
6.4.5 Cerus Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Corporation Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Zika Virus Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sanofi Zika Virus Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 NewLink Genetics
6.6.1 NewLink Genetics Corporation Information
6.6.2 NewLink Genetics Description and Business Overview
6.6.3 NewLink Genetics Zika Virus Sales, Revenue and Gross Margin (2019-2024)
6.6.4 NewLink Genetics Zika Virus Product Portfolio
6.6.5 NewLink Genetics Recent Developments/Updates
6.7 Immunovaccine
6.6.1 Immunovaccine Corporation Information
6.6.2 Immunovaccine Description and Business Overview
6.6.3 Immunovaccine Zika Virus Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Immunovaccine Zika Virus Product Portfolio
6.7.5 Immunovaccine Recent Developments/Updates
6.8 GlaxoSmithKline
6.8.1 GlaxoSmithKline Corporation Information
6.8.2 GlaxoSmithKline Description and Business Overview
6.8.3 GlaxoSmithKline Zika Virus Sales, Revenue and Gross Margin (2019-2024)
6.8.4 GlaxoSmithKline Zika Virus Product Portfolio
6.8.5 GlaxoSmithKline Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Zika Virus Industry Chain Analysis
7.2 Zika Virus Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Zika Virus Production Mode & Process
7.4 Zika Virus Sales and Marketing
7.4.1 Zika Virus Sales Channels
7.4.2 Zika Virus Distributors
7.5 Zika Virus Customers
8 Zika Virus Market Dynamics
8.1 Zika Virus Industry Trends
8.2 Zika Virus Market Drivers
8.3 Zika Virus Market Challenges
8.4 Zika Virus Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
